-
Business Highlights
(1) Policy Amount in Force ···································································································P3 (2) New Policy Amount ·······································································································P3 (3) Annualized Premiums ·····································································································P4 (4) Surrender and Lapse Amount·····························································································P4 (5) Surrender and Lapse Rate ·································································································P5
-
Status of General Account Assets
(1) Investment Performance···································································································P6 (2) Asset Composition ·········································································································P7 (3) Changes in the Amount of Assets by Categories ······································································P7 (4) Investment Income ·········································································································P8 (5) Investment Expenses·······································································································P8 [Reference] Breakdown of Gains/Losses from Derivatives, net·····················································P8
(6) Net Investment Income and Average Daily Balance by Asset Categories ·········································P9 (7) Securities ····················································································································P9 (8) Securities by Contractual Maturity Dates············································································· P11 (9) Stock Holdings by Industry ····························································································· P12 (10) Loans······················································································································· P12 (11) Loans by Contractual Maturity Dates ················································································· P13 (12) Loans to Domestic Companies by Company Size ··································································· P13 (13) Loans by Collateral Type ······························································································· P13 (14) Loans by Industry ········································································································ P14 (15) Foreign Investments ····································································································· P15 (16) Valuation Gains (Losses) on Trading Securities ····································································· P16
(17) Fair Value Information on Securities (Except Trading Securities)················································ P17 (18) Fair Value Information on Monetary Trusts·········································································· P20 (19) Fair Value Information on Land, etc.·················································································· P20 (20) Fair Value Information on Derivative Transactions································································· P21
-
Status of Separate Account Assets
(1) Balance of Separate Account Assets ·················································································· P23 (2) Policy Amount in Force ································································································· P23
- Breakdown of Core Profit and Ordinary Profit
(1) Breakdown of Core Profit······························································································· P24 [Reference] Positive Spread/Negative Spread ······································································ P25
(2) Breakdown of Ordinary Profit·························································································· P25
5. Disclosed Claims Based on Insurance Business Act Standard ··················································· P26 6. Risk Monitored Loans (Based on Insurance Business Act Guidelines) ········································ P26 [Reference] Reserve for Possible Loan Losses ········································································· P26 [Reference] Self-Assessment of Loans ·················································································· P27 7. Solvency Margin Ratio ··································································································· P28 8. Adjusted Net Assets ······································································································· P28 9. Total of General Account Assets and Separate Account AssetsFair Value Information on Financial Instruments ······································································ P29
Percentages are rounded to the nearest relevant percentage point. Therefore, the sums of each percentage do not always amount to 100%.
1. Business Highlights-
Policy Amount in Force
(Number: Thousands, 100 Millions of yen, %)
Category
As of March 31, 2017
As of September 30, 2017
Number
Amount
Number
Amount
Change from Previous FYE (%)
Change from Previous FYE (%)
Individual insurance
1,809
365,380
1,827
101.0
364,457
99.7
Individual term life insurance
1,204
347,724
1,196
99.4
347,174
99.8
Individual annuities
167
12,875
167
99.7
12,752
99.0
Subtotal
1,977
378,256
1,994
100.9
377,209
99.7
Group insurance
-
68,192
-
-
65,671
96.3
Group annuities
-
7,333
-
-
7,241
98.7
Notes:
Policy amount in force for individual annuities is the sum of the funds to be held at the time annuity payments are to commence for an annuity for which annuity payments have not yet commenced and the amount of policy reserve for an annuity for which payments have commenced.
Policy amount in force for group annuities is equal to the amount of outstanding policy reserve.
Amount adding the total insured amount of "J-type product" and "T-type product", the Company's core products, along with term life insurance, and "Kaigo Relief", which was launched in October 2015 to subtotal of individual insurance and individual annuities is as follows. (Number of "J-type product", "T-type product", and "Kaigo Relief" is included in the above table, however amount of these products is not included in policy amount in force because these products do not cover death benefits.)
(Number: Thousands, 100 Millions of yen, %)
Category
As of March 31, 2017
As of September 30, 2017
Number
Amount
Number
Amount
Change from Previous FYE (%)
Change from Previous FYE (%)
Subtotal including "J-type product", "T-type product", and "Kaigo Relief"
1,977
409,922
1,994
100.9
412,518
100.6
"J-type product", "T-type product", and "Kaigo Relief"
[156]
31,666
[176]
[112.8]
35,309
111.5
-
New Policy Amount
(Number: Thousands, 100 Millions of yen, %)
Category
Six Months Ended September 30, 2016
Number
Change (%)
Amount
Change (%)
New policies
Increase from conversion
Individual insurance
99
105.6
18,686
103.9
18,734
(48)
Individual term life insurance
54
100.2
18,428
104.3
18,478
(50)
Individual annuities
2
128.4
212
118.2
212
-
Subtotal
101
106.1
18,898
104.0
18,946
(48)
Group insurance
-
-
35
112.1
35
Group annuities
-
-
0
497.6
0
(Number: Thousands, 100 Millions of yen, %)
Six Months Ended September 30, 2017
Number
Change (%)
Amount
Change (%)
New policies
Increase from conversion
Individual insurance
93
94.2
14,919
79.8
14,955
(35)
Individual term life insurance
47
87.8
14,773
80.2
14,810
(36)
Individual annuities
2
90.2
161
75.9
161
-
Subtotal
95
94.1
15,080
79.8
15,116
(35)
Group insurance
-
-
9
26.7
9
Group annuities
-
-
0
771.0
0
Notes:
Unless stated otherwise, % changes are presented in comparison with the same period of the previous year.
The number of new policies includes increase from conversion.
The amount of new policies and increase from conversion for individual annuities are funds to be held at the time annuity payments are to commence for an annuity.
The new policy amount for group annuities is equal to the initial premium payment.
Amount adding the total insured amount of "J-type product", "T-type product", and "Kaigo Relief" to subtotal of individual insurance and individual annuities is as follows. (Number of "J-type product", "T-type product", and "Kaigo Relief" is included in the above table, however amount of these products is not included in new policy amount because these products do not cover death benefits.)
(Number: Thousands, 100 Millions of yen, %)
Category
Six Months Ended September 30, 2016
Number
Change (%)
Amount
Change (%)
New policies
Increase from conversion
Subtotal including "J-type product" and "T-type product"
101
106.1
23,145
104.0
23,193
(48)
"J-type product" and "T-type product"
[21]
[123.8]
4,246
103.9
4,246
-
(Number: Thousands, 100 Millions of yen, %)
Category
Six Months Ended September 30, 2017
Number
Change (%)
Amount
Change (%)
New policies
Increase from conversion
Subtotal including "J-type product", "T-type product", and "Kaigo Relief"
95
94.1
19,921
86.1
19,957
(35)
"J-type product" and "T-type product" , and "Kaigo Relief"
[25]
[119.0]
4,840
114.0
4,840
-
- Annualized Premiums
Policies in force (Millions of yen, %)
Category
As of March 31, 2017
As of September 30, 2017
Amount
Change from Previous FYE (%)
Amount
Change from Previous FYE (%)
Individual insurance
683,150
106.3
689,983
101.0
Individual annuities
64,658
102.6
63,948
98.9
Total
747,808
106.0
753,932
100.8
Medical benefits, living benefits, and others
85,363
112.1
88,942
104.2
New policies (Millions of yen, %)
Category
Six Months Ended September 30, 2016
Six Months Ended September 30, 2017
Amount
Change (%)
Amount
Change (%)
Individual insurance
40,721
102.8
33,260
81.7
Individual annuities
864
118.9
640
74.1
Total
41,586
103.1
33,900
81.5
Medical benefits, living benefits, and others
6,960
105.5
6,754
97.0
Notes:
The amount of annualized premium is the annual premium amount calculated by multiplying factors according to the premium payment method to a single premium payment amount (for lump-sum payment, the amount is the total premium divided by the insured period).
The amount of "Medical benefits, living benefits, and others" represents annualized premium related to medical benefits (hospitalization benefits, surgical benefits, and others), living benefits (specified illness benefits, nursing care benefits, and others), and waiver of premium benefits (disability cause is excluded but causes such as specific illness and nursing care are included).
New policies include net increase from conversions
- Surrender and Lapse Amount
(Number: Thousands, 100 Millions of yen, %)
Category
Six Months Ended September 30, 2016
Six Months Ended September 30, 2017
Number
Amount
Number
Amount
Change (%)
Change (%)
Change (%)
Change (%)
Individual insurance
61
97.0
11,778
97.9
62
102.1
11,954
101.5
Individual annuities
1
91.6
139
87.5
1
90.1
130
93.2
Total
63
96.8
11,918
97.8
64
101.8
12,085
101.4
Note: Amount adding the total insured amount of "J-type product", "T-type product", and "Kaigo Relief" to subtotal of individual insurance and individual annuities is as follows. (Number of "J-type product", "T-type product", and "Kaigo Relief" is included in the above table, however amount of these products is not included in surrender and lapse amount because these products do not cover death benefits.)
(Number: Thousands, 100 Millions of yen, %)
Category
Six Months Ended September 30, 2016
Six Months Ended September 30, 2017
Number
Amount
Number
Amount
Change (%)
Change (%)
Change (%)
Change (%)
Subtotal including "J-type product", "T-type product", and "Kaigo Relief"
63
96.8
12,613
99.3
64
101.8
13,059
103.5
T&D Holdings Inc. published this content on 13 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 November 2017 06:08:07 UTC.
Original documenthttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material&sid=81820&code=EE8795
Public permalinkhttp://www.publicnow.com/view/28BA2F0FD450E7F9F3B716532235366FDF3D9386